RaySearch Laboratories AB (publ) Interim report January 1 - September 30, 2007

RaySearch Laboratories AB (publ) Interim report January 1 - September 30, 2007

JANUARY 1 - SEPTEMBER 30, 2007
• Net sales for the period amounted to SEK 50.2 M (47.8)
• Profit after tax was SEK 16.8 M (16.5)
• Earnings per share after tax amounted to SEK 1.47 (1.44)
• Operating profit amounted to SEK 22.1 M (22.5)
• Cash flow from operating activities amounted to SEK 25.7 M (16.9)
• New collaboration agreement with Varian Medical Systems was signed in May
• New collaboration agreement with TomoTherapy was signed in August
• Application to the FDA for 510(k) approval for sales of COMPASS product
platform in the US was submitted in August.

CEO COMMENTS

“We are now working intensely on expanding our product portfolio and recently
returned home from the major, annual ASTRO meeting at which we and three of our
partners demonstrated new product concepts that will be launched in the coming
years,” says Johan Löf, CEO of RaySearch.

“We are now entering a highly exciting period with many new product releases,
but it is also pleasing that sales of our existing products continue the
positive trend.”

FOR FURTHER INFORMATION, CONTACT:
Johan Löf, President and CEO
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com


RaySearch Laboratories AB (publ)
Org nr 556322-6157
Sveavägen 25
111 34 Stockholm

ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian Medical Systems, Nucletron, IBA Dosimetry and TomoTherapy. Six
products have been released to date and RaySearch's software is used at over
1,200 clinics in more than 30 countries. In addition, existing license
agreements cover more than 15 other products that are scheduled to be launched
in the coming years. RaySearch was founded in 2000 as a spin-off from Karolinska
Institutet in Stockholm and the company is listed in the MidCap segment on the
OMX Nordic Exchange Stockholm. 

For more information about RaySearch, please visit www.raysearchlabs.com.